Efficacy of capacitive resistive monopolar radiofrequency in the physiotherapeutic treatment of chronic pelvic pain syndrome: study protocol for a randomized controlled trial

A Carralero-Martínez, M A Muñoz Pérez, R Pané-Alemany, L Blanco-Ratto, S Kauffmann, I Ramírez-García, A Carralero-Martínez, M A Muñoz Pérez, R Pané-Alemany, L Blanco-Ratto, S Kauffmann, I Ramírez-García

Abstract

Background: Chronic pelvic pain syndrome (CPPS) is a multifactorial disorder that affects 5.7% to 26.6% of women and 2.2% to 9.7% of men, characterized by hypersensitivity of the central and peripheral nervous system affecting bladder and genital function. People with CPPS have much higher rates of psychological disorders (anxiety, depression, and catastrophizing) that increase the severity of chronic pain and worsen quality of life. Myofascial therapy, manual therapy, and treatment of trigger points are proven therapeutic options for this syndrome. This study aims to evaluate the efficacy of capacitive resistive monopolar radiofrequency (CRMRF) at 448 kHz as an adjunct treatment to other physiotherapeutic techniques for reducing pain and improving the quality of life of patients with CPPS.

Methods: This triple-blind (1:1) randomized controlled trial will include 80 women and men with CPPS. Participants will be randomized into a CRMRF activated group or a CRMRF deactivated group and receive physiotherapeutic techniques and pain education. The groups will undergo treatment for 10 consecutive weeks. At the beginning of the trial there will be an evaluation of pain intensity (using VAS), quality of life (using the SF-12), kinesiophobia (using the TSK-11), and catastrophism (using the PCS), as well as at the sixth and tenth sessions.

Discussion: The results of this study will show that CRMRF benefits the treatment of patients with CPPS, together with physiotherapeutic techniques and pain education. These results could offer an alternative conservative treatment option for these patients.

Trial registration: ClinicalTrials.gov NCT03797911 . Registered on 8 January 2019.

Keywords: Capacitive resistive monopolar radiofrequency; Chronic pelvic pain syndrome; Gynecology; Musculoskeletal pain; Physical therapy; Randomized controlled trial; Therapeutic interventions; Urology.

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Uroweb. Chronic pelvic pain. 2017. . Assessed 14 May 2021.
    1. Valdivia Jimnez MI. Abordaje del dolor en una unidad de suelo plvico. Necesidad de equipos multidisciplinares. Suelo Plvico. 2013;9(1):29–35.
    1. Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Phys. 2014;17(2):e141–e147. doi: 10.36076/ppj.2014/17/E141.
    1. Grinberg K, Granot M, Lowenstein L, Abramov L, Weissman-Fogel I. A common pronociceptive pain modulation profile typifying subgroups of chronic pelvic pain syndromes is interrelated with enhanced clinical pain. Pain. 2017;158(6):1021–1029. doi: 10.1097/j.pain.0000000000000869.
    1. Steege JF, Siedhoff MT. Chronic pelvic pain. Obstet Gynecol. 2014;124(3):616–629. doi: 10.1097/AOG.0000000000000417.
    1. Cheong YC, Smotra G, Williams ACDC. Nonsurgical interventions for the management of chronic pelvic pain. Cochrane Database Syst Rev. 2014;(3):CD008797. 10.1002/14651858.CD008797.pub2. Accessed 16 May 2021.
    1. Twiddy H, Bradshaw A, Chawla R, Johnson S, Lane N. Female chronic pelvic pain: the journey to diagnosis and beyond. Pain Manag. 2017;7(3):155–159. doi: 10.2217/pmt-2016-0052.
    1. Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008;31(Suppl 1):S85–S90. doi: 10.1016/j.ijantimicag.2007.08.028.
    1. Bryant C, Cockburn R, Plante A-F, Chia A. The psychological profile of women presenting to a multidisciplinary clinic for chronic pelvic pain: high levels of psychological dysfunction and implications for practice. J Pain Res. 2016;9:1049–1056. doi: 10.2147/JPR.S115065.
    1. Miller-Matero LR, Saulino C, Clark S, Bugenski M, Eshelman A, Eisenstein D. When treating the pain is not enough: a multidisciplinary approach for chronic pelvic pain. Arch Womens Ment Health. 2016;19(2):349–354. doi: 10.1007/s00737-015-0537-9.
    1. Romo APMS, Gorayeb R, Romo GS, Poli-Neto OB, dos Reis FJC, Rosa-e-Silva JC, Nogueira AA. High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain. Int J Clin Pract. 2009;63(5):707–711. doi: 10.1111/j.1742-1241.2009.02034.x.
    1. Lorenatto C, Petta CA, Navarro MJ, Bahamondes L, Matos A. Depression in women with endometriosis with and without chronic pelvic pain. Acta Obstet Gynecol Scand. 2006;85(1):88–92. doi: 10.1080/00016340500456118.
    1. Williams DA. The importance of psychological assessment in chronic pain. Curr Opin Urol. 2013;23(6):554–559. doi: 10.1097/MOU.0b013e3283652af1.
    1. Till SR, As-Sanie S, Schrepf A. Psychology of chronic pelvic pain: prevalence, neurobiological vulnerabilities, and treatment. Clin Obstet Gynecol. 2019;62(1):22–36. doi: 10.1097/GRF.0000000000000412.
    1. Yosef A, Allaire C, Williams C, et al. Multifactorial contributors to the severity of chronic pelvic pain in women. Am J Obstet Gynecol. 2016;215(6):760. doi: 10.1016/j.ajog.2016.07.023.
    1. McPeak AE, Allaire C, Williams C, Albert A, Lisonkova S, Yong PJ. Pain catastrophizing and pain health-related quality-of-life in endometriosis. Clin J Pain. 2018;34(4):349–356. doi: 10.1097/AJP.0000000000000539.
    1. Sewell M, Churilov L, Mooney S, Ma T, Maher P, Grover SR. Chronic pelvic pain - pain catastrophizing, pelvic pain and quality of life. Scand J Pain. 2018;18(3):441–448. doi: 10.1515/sjpain-2017-0181.
    1. Granot M. Personality traits associated with perception of noxious stimuli in women with vulvar vestibulitis syndrome. J Pain. 2005;6(3):168–173. doi: 10.1016/j.jpain.2004.11.010.
    1. Lowenstein L, FitzGerald MP, Kenton K, Hatchett L, Durazo-Arvizu R, Mueller ER, Goldman K, Brubaker L. Evaluation of urgency in women, with a validated Urgency, Severity and Impact Questionnaire (USIQ) Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(3):301–307. doi: 10.1007/s00192-008-0770-0.
    1. Lowenstein L, Vardi Y, Deutsch M, Friedman M, Gruenwald I, Granot M, Sprecher E, Yarnitsky D. Vulvar vestibulitis severity--assessment by sensory and pain testing modalities. Pain. 2004;107(1-2):47–53. doi: 10.1016/j.pain.2003.09.012.
    1. van Lankveld JJ, Granot M, Weijmar Schultz WC, Binik YM, Wesselmann U, Pukall CF, Bohm-Starke N, Achtrari C. Womens sexual pain disorders. J Sex Med. 2010;7(1 Pt 2):615–631. doi: 10.1111/j.1743-6109.2009.01631.x.
    1. Allaire C, Williams C, Bodmer-Roy S, et al. Chronic pelvic pain in an interdisciplinary setting: 1-year prospective cohort. Am J Obstet Gynecol. 2018;218(1):114.e1–e114.e12. doi: 10.1016/j.ajog.2017.10.002.
    1. Thomtn J, Karlsson A. Psychological factors in genital pain: the role of fear-avoidance, pain catastrophizing and anxiety sensitivity among women living in Sweden. Scand J Pain. 2014;5(3):193–199. doi: 10.1016/j.sjpain.2014.01.003.
    1. Grinberg K, Weissman-Fogel I, Lowenstein L, Abramov L, Granot M. How does myofascial physical therapy attenuate pain in chronic pelvic pain syndrome? Pain Res Manag. 2019;2019:6091257. doi: 10.1155/2019/6091257.
    1. Klotz S, Ketels G, Lwe B, Brnahl C. Myofascial findings and phychopathological factors in patients with chronic pelvic pain syndrome. Pain Med. 2018;0:1–11.
    1. Grinberg K, Sela Y, Nissanholtz-Gannot R. New insights about Chronic Pelvic Pain Syndrome (CPPS) Int J Environ Res Public Health. 2020;17(9):3005. doi: 10.3390/ijerph17093005.
    1. Klotz S, Schn M, Ketels G, Lwe B, Brnahl C. Physiotherapy management of patients with chronic pelvic pain (CPP): a systematic review. Physiother Theory Pract. 2019;35(6):516–532. doi: 10.1080/09593985.2018.1455251.
    1. Osti R, Pari C, Salvatori G, Massari L. Tri-length laser therapy associated to tecar therapy in the treatment of lowback pain in adults: a preliminary report of a prospective case series. Lasers Med Sci. 2015;30(1):407–412. doi: 10.1007/s10103-014-1684-3.
    1. Kumaran B, Watson T. Thermal build-up, decay and retention responses to local therapeutic application of 448kHz capacitive resistive monopolar radiofrequency: a prospective randomised crossover study in healthy adults. Int J Hyperth. 2015;31(8):883–895. doi: 10.3109/02656736.2015.1092172.
    1. beda A, Hernndez-Bule ML, Trillo MA, Cid MA, Leal J. Cellular response to non-thermal doses of radiofrequency currents used in electro-thermal therapy. J Jpn Soc Laser Surg Med. 2006;27(3):187.
    1. Yokota Y, Tashiro Y, Suzuki Y, Tasaka S, Matsushita T, et al. Effect of capacitive and resistive electric transfer on tissue temperature, muscle flexibility, and blood circulation. J Nov Physiother. 2017;7:325. doi: 10.4172/2165-7025.1000325.
    1. Watson T. Electrotherapy: evidence-based practice. 12. London: Elsevier Churchill Livingstone; 2008.
    1. Lehmann J, DeLateur B. Therapeutic heat. In: Lehmann J, editor. Therapeutic heat and cold. 4. Baltimore: Williams & Wilkins; 1990. pp. 470–474.
    1. Prentice W, Draper D. Shortwave and microwave diathermy. In: Prentice W, editor. Therapeutic modalities in rehabilitation. 4. New York: McGraw-Hill; 2011. pp. 433–462.
    1. Kumaran B, Watson T. Radiofrequency-based treatment in therapyrelated clinical practice a narrative review. Part I: acute conditions. Phys Ther Rev. 2015;20(4):241–254. doi: 10.1179/1743288X15Y.0000000016.
    1. Fuentes-Mrquez P, Cabrera-Martos I, Valenza MC. Physiotherapy interventions for patients with chronic pelvic pain: a systematic review of the literature. Physiother Theory Pract. 2019;35(12):1131–1138. doi: 10.1080/09593985.2018.1472687.
    1. Notarnicola A, Maccagnano G, Gallone MF, Covelli I, Tafuri S, Moretti B. Short term efficacy of capacitive-resistive diathermy therapy in patients with low back pain: a prospective randomized controlled trial. J Biol Regul Homeost Agents. 2017;31(2):509–515.
    1. Wiegerinck JI, Kerkhoffs GM, van Sterkenburg MN, Sierevelt IN, van Dijk CN. Treatment for insertional Achilles tendinopathy: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2013;21(6):1345–1355. doi: 10.1007/s00167-012-2219-8.
    1. Costantino C, Vulpiani MC, Romiti D, Vetrano M, Saraceni VM. Cryoultrasound therapy in the treatment of chronic plantar fasciitis with heel spurs. A randomized controlled clinical study. Eur J Phys Rehabil Med. 2014;50(1):39–47.
    1. Lideo L, Milan R. Ultrasound monitoring of shortwave diathermic treatment of gastrocnemius strain in a dog. J Ultrasound. 2013;16(4):231–234. doi: 10.1007/s40477-013-0044-7.
    1. Bonder JH, Chi M, Rispoli L. Myofascial pelvic pain and related disorders. Phys Med Rehabil Clin N Am. 2017;28(3):501–515. doi: 10.1016/j.pmr.2017.03.005.
    1. Simons DG, Travell JG. Dolor y disfuncin miofascial: El manual de los puntos gatillo (vol.2): extremidades inferiores: Ed. Panamericana; 2010.
    1. Charles D, Hudgins T, MacNaughton J, Newman E, Tan J, Wigger M. A systematic review of manual therapy techniques, dry cupping and dry needling in the reduction of myofascial pain and myofascial trigger points. J Bodyw Mov Ther. 2019;23(3):539–546. doi: 10.1016/j.jbmt.2019.04.001.
    1. Montenegro ML, Braz CA, Rosa-e-Silva JC, Candido-dos-Reis FJ, Nogueira AA, Poli-Neto OB. Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain. BMC Anesthesiol. 2015;15(1):175. doi: 10.1186/s12871-015-0155-0.
    1. Melzack R, Wall P. Pain mechanisms: a new theory. Science. 1965;150(3699):971–979. doi: 10.1126/science.150.3699.971.
    1. Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. Relating chronic pelvic pain and endometriosis to signs of sensitization and myofascial pain and dysfunction. Semin Reprod Med. 2017;35(1):88–97. doi: 10.1055/s-0036-1597123.
    1. Kaya S, Hermans L, Willems T, Roussel N, Meeus M. Central sensitization in urogynecological chronic pelvic pain: a systematic literature review. Pain Phys. 2013;16(4):291–308. doi: 10.36076/ppj.2013/16/291.
    1. Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K, Meeusen R. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets. 2015;19(4):565–576. doi: 10.1517/14728222.2014.994506.
    1. Laimi K, Mkila A, Brlund E, Katajapuu N, Oksanen A, Seikkula V, et al. Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: a systematic review. Clin Rehabil. 2018;32(4):440–450. doi: 10.1177/0269215517732820.
    1. Gould D, Kelly D, Goldstone L, Gammon J. Visual analogue scale (VAS) J Clin Nurs. 2001;10(5):697–706. doi: 10.1046/j.1365-2702.2001.00525.x.
    1. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. New York: Oxford University Press; 1989.
    1. Ware JE, Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233. doi: 10.1097/00005650-199603000-00003.
    1. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171–1178. doi: 10.1016/S0895-4356(98)00109-7.
    1. Vilagut G, Ferrer M, Rajmil M, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J. El cuestionario de salud SF-36 espa.ol: una d.cada de experiencia y nuevos desarrollos. Gac Sanit. 2005;19(2):135–150. doi: 10.1157/13074369.
    1. Alonso J, Regidor E, Barrio G, Prieto L, Rodriguez C, de la Fuente L. Valores poblacionales de referencia de la versi.n espa.ola del Cuestionario de Salud SF- 36. Med Clin. 1998;111:410–416.
    1. Miller R, Kori S, Todd D. The Tampa Scale: a measure of kinesiophobia. Clin J Pain. 1991;7(1):51. doi: 10.1097/00002508-199103000-00053.
    1. Gmez-Prez L, Lpez-Martnez AE, Ruiz-Prraga GT. Psychometric properties of the Spanish version of the Tampa Scale for Kinesiophobia (TSK) J Pain. 2011;12(4):425–435. doi: 10.1016/j.jpain.2010.08.004.
    1. Sullivan M, Bishop S, Pivik J. The pain catastrophizing scale: development and validation. Physchol Assess. 1995;7(4):524–532. doi: 10.1037/1040-3590.7.4.524.
    1. Garca Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. Validation of the spanish version of the pain catastrophizing scale in fibromyalgia. Med Clin. 2008;131(13):487–493. doi: 10.1157/13127277.
    1. Parker SL, Adogwa O, Paul AR, Anderson WN, Aaronson O, Cheng JS, McGirt MJ. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis. J Neurosurg Spine. 2011;14(5):598–604. doi: 10.3171/2010.12.SPINE10472.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren